FMS vs. MDT: Fresenius Medical Care vs. Medtronic Stock Comparison

Company Profile

Fresenius Medical Care (FMS) and Medtronic (MDT) both fall under the Health Care Equipment & Services industry group, but FMS is classified in Health Care Providers & Services while MDT is classified in Health Care Equipment & Supplies.

Medtronic (MDT) trades as ordinary local shares, while Fresenius Medical Care (FMS) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medtronic (MDT) is heavily traded at around 16.48M shares per day, whereas Fresenius Medical Care (FMS) sees a more moderate 954.21K — larger orders in the latter may require more patience and tighter control over order sizing.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Fresenius Medical Care (FMS) at 7.84% and Medtronic (MDT) at 10.65% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Medtronic (MDT) at 13.93% retains a top-quartile share of revenue as profit, ahead of Fresenius Medical Care (FMS) at 4.22%, which keeps about the industry-typical share.

Medtronic (MDT) at 19.33% operates in the top operating margin quartile, ahead of Fresenius Medical Care (FMS) at 9.63%, which runs around its industry’s norm.

Profitability Metrics

Growth

Medtronic (MDT) at 8.43% is around its peer norm for revenue growth, while Fresenius Medical Care (FMS) at 1.51% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Fresenius Medical Care (FMS) at 83.61% sits in the top EPS growth quartile, while Medtronic (MDT) at 3.32% is closer to the peer norm — faster per-share earnings growth for FMS.

Growth Metrics

Financial Strength

Medtronic (MDT) at 2.07 keeps current ratio within its industry’s typical mid-range, while Fresenius Medical Care (FMS) at 0.99 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for FMS.

Both Fresenius Medical Care (FMS) at 0.79 and Medtronic (MDT) at 0.55 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Both Fresenius Medical Care (FMS) at 6.30% and Medtronic (MDT) at 2.72% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

Both Fresenius Medical Care (FMS) at 50.14% and Medtronic (MDT) at 70.02% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

Dividend Metrics

Valuation

Fresenius Medical Care (FMS) at 13.53 sits in the cheaper P/E ratio quartile, while Medtronic (MDT) at 25.01 is closer to its industry’s usual earnings multiple — a discount for FMS, though growth and earnings durability still matter.

Fresenius Medical Care (FMS) at 0.62 sits in the cheaper P/S ratio quartile while Medtronic (MDT) at 3.47 prices around its industry’s middle — FMS costs less per dollar of sales, though read it alongside growth and margins.

Fresenius Medical Care (FMS) at 0.85 sits in the lower P/B ratio quartile against book while Medtronic (MDT) at 2.59 is valued near its industry’s middle — FMS is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics